血造干细胞移植后的心血管事件:发生率和危险因素
Alexi Vasbinder1, Christopher W Hoeger2, Tonimarie Catalan1
1Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
JACC. CardioOncology
|January 11, 2024
概括
造血干细胞移植 (HSCT) 的短期心血管风险较低. 长期心血管事件在异性HSCT接受者和具有先前心脏病的患者中更常见.
科学领域:
- 心脏病学 心脏病学
- 血液学 血液学 血液学
- 移植医学 移植医学
背景情况:
- 造血干细胞移植 (HSCT) 是一个拯救生命的手术.
- HSCT与显著的心血管 (CV) 并发症有关.
- 了解这些心血管风险对于患者管理至关重要.
研究的目的:
- 为了确定HCST后短期和长期CV事件的发生率.
- 为了确定成年HSCT接受者的心血管并发症的风险因素.
- 在当代HSCT队列中描述CV结果.
主要方法:
- 进行了一项多中心观察性研究.
- 包括接受自主或异性HSCT (2008-2019) 的成年患者.
- 短期 (≤100天) 和长期 (>100天) 的心血管结局 (死亡,心脏病发作,高血压,心肌动,中风,静脉动) 被跟踪.
主要成果:
- 在3354名患者中,CV事件的100天和5年累计发病率分别为4.1%和13.9%.
- 心房动/动和心力衰竭是最常见的CV事件.
- 全基因接受者有较高的长期CV事件发生率 (16.4%) 与自身接受者 (12.1%).
- 以前存在的CV并发症增加了长期CV事件的风险.
结论:
- 在HSCT后,短期CV事件的发生率很低.
- 长期CV事件在异性HSCT接受者中更为普遍.
- 之前存在的心血管并发症是HSCT后长期心血管事件的重要风险因素.
相关概念视频
Bone Marrow Sampling and Transplants
332
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Stem Cell Therapy for Tissue Regeneration
4.1K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K


